Transcription Factor AP2ε: A Potential Predictor of Chemoresistance in Patients With Gastric Cancer. [electronic resource]
- Technology in cancer research & treatment Apr 2016
- 285-95 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1533-0338
10.1177/1533034615577028 doi
Adult Aged Aged, 80 and over Antineoplastic Agents--pharmacology Biomarkers, Tumor--metabolism Cell Line, Tumor DNA Methylation Deoxycytidine--pharmacology Drug Resistance, Neoplasm Female Fluorouracil--pharmacology Gene Expression Regulation, Neoplastic Humans Male Middle Aged ROC Curve Stomach Neoplasms--drug therapy Transcription Factor AP-2--metabolism